InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.550
0.00 (0.00%)
Jun 25, 2026, 9:35 AM EDT - Market open
InMed Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 3.22 | 4.94 | 4.6 | 4.14 | 1.09 | - | |
Revenue Growth (YoY) | - | 7.50% | 11.18% | 279.60% | - | - |
Cost of Revenue | 2.26 | 3.24 | 3.5 | 2.73 | 0.55 | - |
Gross Profit | 0.96 | 1.71 | 1.1 | 1.4 | 0.54 | - |
Selling, General & Admin | 7.15 | 6.56 | 5.8 | 5.85 | 6.87 | 4.48 |
Depreciation & Amortization Expenses | 0.21 | 0.21 | 0.22 | 0.2 | 0.19 | 0.12 |
Research & Development | 2.35 | 2.85 | 3.22 | 3.73 | 7.28 | 5.34 |
Other Operating Expenses | 0.04 | 0.03 | 0.06 | 0.05 | 3.47 | - |
Total Operating Expenses | 9.75 | 9.65 | 9.3 | 9.83 | 17.81 | 9.94 |
Operating Income | -8.79 | -7.95 | -8.2 | -8.43 | -17.26 | -9.94 |
Interest Expense | -0.02 | -0.37 | - | - | - | -0.36 |
Other Non-Operating Income (Expense) | 0.27 | 0.16 | 0.53 | 0.49 | -1.34 | 0.1 |
Total Non-Operating Income (Expense) | 0.25 | -0.22 | 0.53 | 0.49 | -1.34 | -0.26 |
Pretax Income | -5.71 | -8.16 | -7.67 | -7.93 | -18.6 | -10.2 |
Provision for Income Taxes | - | - | -0.01 | -0.01 | - | - |
Net Income | -2.79 | -8.16 | -7.66 | -7.92 | -18.6 | -10.2 |
Earnings From Discontinued Operations | -0.17 | - | - | - | - | - |
Net Income to Common | -8.51 | -8.16 | -7.68 | -7.95 | -18.6 | -10.2 |
Shares Outstanding (Basic) | 3 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 3 | 1 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 363.37% | 156.13% | 211.26% | 336.58% | 108.65% | 28.72% |
EPS (Basic) | -2.11 | -8.36 | -20.14 | -65.00 | -663.40 | -759.20 |
EPS (Diluted) | -2.11 | -8.36 | -20.14 | -65.00 | -663.40 | -759.20 |
Free Cash Flow | -7.46 | -7.77 | -7 | -7.45 | -15.62 | -9.79 |
Free Cash Flow Per Share | -2.22 | -7.96 | -18.36 | -60.81 | -557.13 | -728.62 |
Gross Margin | 29.89% | 34.53% | 23.94% | 33.93% | 49.89% | - |
Operating Margin | -272.54% | -160.77% | -178.27% | -203.77% | -1584.71% | - |
Profit Margin | -86.61% | -165.14% | -166.63% | -191.54% | -1707.32% | - |
FCF Margin | -231.35% | -157.14% | -152.14% | -180.02% | -1434.03% | - |
EBITDA | -8.21 | -7.41 | -7.59 | -7.83 | -16.75 | -9.71 |
EBITDA Margin | -254.57% | -149.95% | -165.12% | -189.36% | -1537.73% | - |
EBIT | -8.79 | -7.95 | -8.2 | -8.43 | -17.26 | -9.94 |
EBIT Margin | -272.54% | -160.77% | -178.27% | -203.77% | -1584.71% | - |
Effective Tax Rate | - | 0.00% | 0.09% | 0.17% | 0.00% | 0.00% |